News

Here's what lies ahead Drug giant promises $50 billion U.S. investment Drug giant promises $50 billion U.S. investment Bay ...
When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced several strategic leadership appointments within its Drug Product team. These ...
Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...
With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...
The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished ...
The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...
During a live event, Hans Lee, MD, and participants shared their perspectives on current and upcoming treatment approaches in ...
Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape for neovascular age-related ...
The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
The first prediction tool of its kind for early-stage classic Hodgkin lymphoma provides estimates using continuous variables capturing nonlinear context.